This announcement is a separate document:
健友股份关于公司可转换公司债券2024年跟踪评级结果的公告
Nanjing King-Friend Biochemical Pharmaceutical's announcement regarding the tracking rating results of the company's convertible bonds due in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.